Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

UK Health Security Agency

- PMLiVE

UKHSA and The Pirbright Institute collaborate to develop vaccines against henipaviruses

There are currently no licensed vaccines or treatments for the Nipah virus

- PMLiVE

AstraZeneca announces plans to invest £650m in UK to boost life sciences sector

The investment will also help to enhance public health protection and pandemic preparedness in the UK

- PMLiVE

New nanoparticle to deliver vaccines and generate strong immune responses at lower dose

MOF activates the innate immune system through TLRs to provoke strong immune responses

Can Cinderella save us?

PACE announces partnership with UKHSA to tackle antimicrobial resistance

AMR is designated by WHO as one of the top ten threats to global public health

- PMLiVE

GSK partners with DNA specialist Elegen to advance medicines and vaccines

GSK will leverage Elegen’s cell-free synthetic DNA production technology

- PMLiVE

UKHSA publishes five-year strategy to detect risk-posing pathogens in UK

The strategy will help to improve the UK's response to infectious disease threats

- PMLiVE

New WHO initiative to prioritise endemic pathogens for vaccine development

Value profiles of 16 pathogens with vaccines in clinical development will be featured

- PMLiVE

Moderna and CEPI enter pandemic preparedness partnership

The partnership aims to expand infectious disease targets for mRNA vaccine technology

- PMLiVE

Differences in immune responses could optimise future COVID-19 vaccines

Vulnerability to different mutations was linked to previous infections and vaccination

- PMLiVE

UKHSA secures UK-based vaccine deal for future influenza pandemics

CSL Sequiris will be ready to produce over 100 million influenza pandemic vaccines

- PMLiVE

UK government unveils vaccine development hub to strengthen pandemic defences

The centre will support the development of vaccines against new threats

- PMLiVE

UKHSA data reveals a 45% decline in hepatitis C prevalence in England

More than 80,000 people have been treated for the virus by NHS England since 2015

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links